With the federal election about a month away, Canada’s political parties are rolling out their election platforms, making a host of promises to improve health care, employment insurance, the minimum wage and pension legislation. If elected, the Liberal Party of Canada, New Democratic Party and Green Party of Canada are all promising to implement a national pharmacare program. […]
The cost of employer-provided health benefits in Canada is forecasted to rise six per cent in 2020, outpacing general inflation by 1.9 per cent, according to a 2020 trend rates report by Aon. The increase is due to higher costs from the rising spend on drugs in general, noted a press release. Globally, costs for employer-sponsored medical plans in 2020 are expected to increase […]
Five major pharmaceutical companies have filed a constitutional challenge to the federal government’s incoming changes to the Patented Medicine Prices Review Board. The complaint was filed in Quebec Superior Court by the Canadian subsidiaries of Merck & Co., Janssen Inc., Bayer, Boehringer Ingelheim Ltd. and Servier Inc. In statements provided to Benefits Canada, the companies […]
Private plan sponsors can expect to see lower drug prices resulting from recent changes to the Patented Medicine Prices Review Board, but there may also be unintended consequences. The reforms, announced Aug. 9 and expected to come into effect July 1, 2020, will update the reference countries Canada uses to compare its prices internationally. They’ll […]
As plan sponsors continue to look for ways to control drug plan spending, a new study from the University of British Columbia shows that switching from an open to a closed formulary can save big dollars. The study, published this month in the Canadian Medical Association Journal Open, analyzed what happened when the B.C. Hospital […]
On Friday, the federal government announced the final amendments to the Patented Medicine Prices Review Board regulations, estimating the reforms will save Canadians about $13 billion in the next decade and lay the foundation for national pharmacare. The amendments, which were put forward by the government in a consultation in May 2017, include an update […]
Prince Edward Island has added six new drugs to the provincial formulary. People dealing with arthritis, diabetes, chronic obstructive pulmonary disease, lung cancer, heart failure and those receiving radiation therapy will now have help in paying for prescription medications. The promise to help provide better access to medications was made in the 2019-20 provincial budget […]
Quebec’s universal pharmacare program offers better drug coverage and quicker approval for new drugs coming to market than the rest of Canada, according to a new study by the Fraser Institute. Looking at drugs approved by Health Canada between 2008 and 2017, the report found Quebec went on to cover 33.4 per cent of them, […]
The Canadian Institute of Actuaries is recommending that any future national pharmacare system includes an actuary to oversee its revenue, expenses and funding status. “Canada’s actuaries — with public interest in mind — advise that any national pharmacare program should be based on sound risk management, financing and insurance principles,” noted the CIA in a press release. The […]
Industry groups had mixed feelings about an expert panel’s report calling for a single-payer pharmacare plan. Released on Wednesday by Eric Hoskins, former Ontario health minister, the report recommended Canada and the provinces work together to create a unified program that addresses the country’s patchwork of prescription drug plans. Provinces and territories, the panel said, […]